Skip to main content
. 2021 Nov 17;9(11):1705. doi: 10.3390/biomedicines9111705

Figure 4.

Figure 4

Immunocaptured CD63+ and MHC-I+ EVs released from WT Jurkat T cells were co-cultured with HUVEC for 3 days. Differential gene expression of HUVEC untreated vs. CD63+ EV or MHC-I+ EV treated HUVEC was determined using microarray analysis. (A) GO enrichment pathway network of untreated HUVEC vs. cells treated with WT Jurkat CD63+ EVs (>1.5 ± fold change, p ≤ 0.05). (B) GO enrichment pathway network of untreated HUVEC vs. cells treated with WT Jurkat MHC-I+ EVs (>1.5 ± fold change, p ≤ 0.05). Supplemental Materials Data files related with (A,B); Data/s2A, /Data/s2B, /Data/s2C.